Peptide record

TPDB09619

Antibacterial Anticancer Antifungal Antiparasitic Toxicity standard
20 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB09619
Antibacterial Anticancer Antifungal Antiparasitic Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia ACP740 _ACP240 AFP-GFuse Antifungipept CAFPdb ToxinPred 3.0
standard
No
A 20-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
GLFTLIKCAYQLIAPTVACN
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C98H159N23O26S2
RDEHMSW
AL
2139.60
8.28
1
0
11
+1
-0.88
1.110
127.00
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
1615
0.75
7
Residue Composition
number
3
A
0
R
1
N
0
D
2
C
0
E
1
Q
1
G
0
H
2
I
3
L
1
K
0
M
1
F
1
P
0
S
2
T
0
W
1
Y
1
V
Amino Acid Distribution
A: 3 R: 0 N: 1 D: 0 C: 2 E: 0 Q: 1 G: 1 H: 0 I: 2 L: 3 K: 1 M: 0 F: 1 P: 1 S: 0 T: 2 W: 0 Y: 1 V: 1
Chemical Descriptors
20 reviewed residue count
C98H159N23O26S2 sequence-only estimate (linear, free termini)
2139.60 sequence-only estimate (linear, free termini)
8.28 sequence-only estimate (linear, free termini)
+1 sequence-only estimate (linear, free termini)
-0.88 sequence-only estimate (linear, free termini)
1.110 sequence-only estimate (linear, free termini)
Evidence Records 14 records
Evidence 1 Activity

Activity

MIC
Antibacterial
35.6 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
active against E. coli (MIC 35.6 ug/ml), S. aureus (MIC 17.8 ug/ml), B. subtilis (MIC 35.6 ug/ml), and C. albicans (MIC 8.9 ug/ml
Evidence 2 Activity

Activity

MIC
Antibacterial
17.8 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP

Other

active against E. coli (MIC 35.6 ug/ml), S. aureus (MIC 17.8 ug/ml), B. subtilis (MIC 35.6 ug/ml), and C. albicans (MIC 8.9 ug/ml). Aslo histamine release. U
Evidence 3 Activity

Activity

MIC
Antibacterial
35.6 µg/mL

Target

B. subtilis

Source & Reference

dbAMP DRAMP

Other

active against E. coli (MIC 35.6 ug/ml), S. aureus (MIC 17.8 ug/ml), B. subtilis (MIC 35.6 ug/ml), and C. albicans (MIC 8.9 ug/ml). Aslo histamine release. Updated 5/2020 7/2021
Evidence 4 Activity

Activity

MIC
Antibacterial
8.9 µg/mL

Target

Candida albicans

Source & Reference

dbAMP DRAMP

Other

t E. coli (MIC 35.6 ug/ml), S. aureus (MIC 17.8 ug/ml), B. subtilis (MIC 35.6 ug/ml), and C. albicans (MIC 8.9 ug/ml). Aslo histamine release. Updated 5/2020 7/2021
Evidence 5 Activity

Activity

MIC
Antifungal
35.6 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
active against E. coli (MIC 35.6 ug/ml), S. aureus (MIC 17.8 ug/ml), B. subtilis (MIC 35.6 ug/ml), and C. albicans (MIC 8.9 ug/ml
Evidence 6 Activity

Activity

MIC
Antifungal
17.8 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

active against E. coli (MIC 35.6 ug/ml), S. aureus (MIC 17.8 ug/ml), B. subtilis (MIC 35.6 ug/ml), and C. albicans (MIC 8.9 ug/ml). Aslo histamine release. U
Evidence 7 Activity

Activity

MIC
Antifungal
35.6 µg/mL

Target

B. subtilis

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

active against E. coli (MIC 35.6 ug/ml), S. aureus (MIC 17.8 ug/ml), B. subtilis (MIC 35.6 ug/ml), and C. albicans (MIC 8.9 ug/ml). Aslo histamine release. Updated 5/2020 7/2021
Evidence 8 Activity

Activity

MIC
Antifungal
8.9 µg/mL

Target

Candida albicans

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

t E. coli (MIC 35.6 ug/ml), S. aureus (MIC 17.8 ug/ml), B. subtilis (MIC 35.6 ug/ml), and C. albicans (MIC 8.9 ug/ml). Aslo histamine release. Updated 5/2020 7/2021
Evidence 9 Activity

Activity

MIC
Antiparasitic
35.6 µg/mL

Target

Escherichia coli

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets.
active against E. coli (MIC 35.6 ug/ml), S. aureus (MIC 17.8 ug/ml), B. subtilis (MIC 35.6 ug/ml), and C. albicans (MIC 8.9 ug/ml
Evidence 10 Activity

Activity

MIC
Antiparasitic
17.8 µg/mL

Target

Staphylococcus aureus

Source & Reference

DRAMP

Other

active against E. coli (MIC 35.6 ug/ml), S. aureus (MIC 17.8 ug/ml), B. subtilis (MIC 35.6 ug/ml), and C. albicans (MIC 8.9 ug/ml). Aslo histamine release. U
Evidence 11 Activity

Activity

MIC
Antiparasitic
35.6 µg/mL

Target

B. subtilis

Source & Reference

DRAMP

Other

active against E. coli (MIC 35.6 ug/ml), S. aureus (MIC 17.8 ug/ml), B. subtilis (MIC 35.6 ug/ml), and C. albicans (MIC 8.9 ug/ml). Aslo histamine release. Updated 5/2020 7/2021
Evidence 12 Activity

Activity

MIC
Antiparasitic
8.9 µg/mL

Target

Candida albicans

Source & Reference

DRAMP

Other

t E. coli (MIC 35.6 ug/ml), S. aureus (MIC 17.8 ug/ml), B. subtilis (MIC 35.6 ug/ml), and C. albicans (MIC 8.9 ug/ml). Aslo histamine release. Updated 5/2020 7/2021
Evidence 13 Activity

Activity

0% Hemolysis
Toxicity
50 µg/mL
Hemolytic Cytotoxic
0% Hemolysis | 50 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Anti-infection peptidomics of amphibian skin. | Mol Cell Proteomics | 2007
Evidence 14 Activity

Activity

(4.5±2.1)% degranulation
Toxicity
50 µg/mL
Cytotoxic
(4.5±2.1)% degranulation | 50 | µg/mL | target cell: Human mast cells

Target

Human mast cells

Source & Reference

NA
DBAASP
Anti-infection peptidomics of amphibian skin. | Mol Cell Proteomics | 2007